Nova Mentis Life Science Corp. (NMLSF)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -277.53 Thousand | -1.44 Million | -1.94 Million | -856.53 Thousand | -878.81 Thousand | -1.37 Million |
| Net Income | -1.22 Million | -2.46 Million | -2.68 Million | -23.24 Million | -1.39 Million | -3.57 Million |
| Depreciation & Amortization | 2941.00 | 3792.00 | 4998.00 | 6820.00 | 9798.00 | 8647.00 |
| Deferred income taxes | -358.47 Thousand | 764.77 Thousand | -111.97 Thousand | 4.09 Million | 196.68 Thousand | 1108.00 |
| Stock-based compensation | 353.37 Thousand | 328.45 Thousand | 348.44 Thousand | 894.08 Thousand | 266.21 Thousand | 1.98 Million |
| Change in working capital | 4354.00 | -2433.00 | 629.88 Thousand | 24.63 Thousand | 67.33 Thousand | 220.34 Thousand |
| Other non-cash items | 586.22 Thousand | -72.31 Thousand | -132.93 Thousand | 17.36 Million | -20.75 Thousand | -14.38 Thousand |
| Investing Cash Flow | - | - | 29.63 Thousand | 2.9 Million | 413.42 Thousand | -2.48 Million |
| Investments in PPE | - | - | - | 434.42 Thousand | - | -40.62 Thousand |
| Acquisitions | - | - | - | 2.6 Million | -413.57 Thousand | -964.83 Thousand |
| Investment purchases | - | - | - | -434.42 Thousand | -413.57 Thousand | -1.55 Million |
| Sales/Maturities of investments | - | - | 29.63 Thousand | 733.37 Thousand | 827 Thousand | 68.42 Thousand |
| Other Investing Activities | - | - | 29.63 Thousand | -434.42 Thousand | 413.57 Thousand | -2.44 Million |
| Financing Cash Flow | 19.1 Thousand | 1.49 Million | - | - | 150 Thousand | 3.05 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 19.1 Thousand | 1.48 Million | - | - | 150 Thousand | 3.05 Million |
| Other Financing Activities | 19.1 Thousand | 8400.00 | - | - | 150 Thousand | 3.05 Million |
| Accounts receivables | 784.00 | 62.45 Thousand | -52.89 Thousand | -9130.00 | 61.09 Thousand | -14.21 Thousand |
| Accounts payables | - | - | - | 9130.00 | -61.09 Thousand | - |
| Inventory | - | - | - | 12.67 Thousand | -18.1 Thousand | - |
| Other working capital | 3570.00 | -64.89 Thousand | 682.78 Thousand | 11.96 Thousand | 85.44 Thousand | 234.56 Thousand |
| Cash at beginning of period | -707.84 Thousand | 218.73 Thousand | 2.13 Million | 87 Thousand | 402.39 Thousand | 1.21 Million |
| Cash at end of period | 8088.00 | 266.51 Thousand | 218.73 Thousand | 2.13 Million | 87 Thousand | 402.39 Thousand |
| Capital Expenditure | - | - | - | 434.42 Thousand | - | -40.62 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 715.93 Thousand | 47.78 Thousand | -1.91 Million | 2.04 Million | -315.38 Thousand | -808.67 Thousand |
| Free Cash Flow | -277.53 Thousand | -1.44 Million | -1.94 Million | -422.1 Thousand | -878.81 Thousand | -1.41 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -90.57 Thousand | -144.37 Thousand | -209.56 Thousand | -1.22 Million | -184.06 Thousand | -302.79 Thousand |
| Depreciation & Amortization | 577.00 | 578.00 | 735.00 | 2941.00 | 736.00 | 735.00 |
| Deferred income taxes | - | - | - | -358.47 Thousand | - | - |
| Stock-based compensation | - | - | - | 353.37 Thousand | - | - |
| Change in working capital | 80.24 Thousand | 97.53 Thousand | 192.47 Thousand | 590.57 Thousand | 190.32 Thousand | 205.56 Thousand |
| Other non-cash items | -2257.00 | 1657.00 | 1310.00 | 358.47 Thousand | -940.00 | 1881.00 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | 60 Thousand | - | 19.1 Thousand | - | - |
| Debt repayment | - | -60 Thousand | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 19.1 Thousand | - | - |
| Other Financing Activities | - | 60 Thousand | - | 19.1 Thousand | - | - |
| Accounts receivables | 3411.00 | -501.00 | 160.00 | 784.00 | 2412.00 | -411.00 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 76.82 Thousand | 98.03 Thousand | 192.31 Thousand | 589.79 Thousand | 187.91 Thousand | 205.97 Thousand |
| Cash at beginning of period | 21.82 Thousand | 8088.00 | 24.44 Thousand | 266.51 Thousand | 17.44 Thousand | 113.94 Thousand |
| Cash at end of period | 12.06 Thousand | 21.82 Thousand | 8088.00 | 8088.00 | 24.44 Thousand | 17.44 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -9761.00 | 13.73 Thousand | -16.35 Thousand | -258.43 Thousand | 6999.00 | -96.49 Thousand |
| Free Cash Flow | -9761.00 | -46.26 Thousand | -16.35 Thousand | -277.53 Thousand | 6999.00 | -96.49 Thousand |
PPERF
CELH
CMCLF
3RG
NDTV
2294